CRCA P&T medication groupings get user-friendly enhancement
As part of our commitment to continuous improvement, we’re excited to announce a new enhancement to CRCATM (Comparative Rapid Cycle Analytics®) P&T, our comprehensive, real-world pharmacy analytics platform. It’s the first in a series of planned enhancements for the platform, and the first sign of how we’re benefitting from additional development resources since joining The Craneware Group last year.
The user interface enhancement centers on the POP-BUILDER RxTM module in CRCA, which allows users to build real-world patient populations and compare medication use, patient encounter types and comorbidities. Specifically, it adds new functionality to the Manage Medication Groups function.
Previously, those cards offered a static list view without the ability to search medication groups or see any actionable data related to those medications. The update, which was rolled out to users in early April, reduces the number of steps that users must take to evaluate their data and see actionable results within CRCA P&T.
Now, when you pull up a group of medications or a single drug, you get an improved at-a-glance summary without having to first build a population around it. The new view lists:
- Medication or medication groups, as named by the user
- The Group ID assigned to the group
- A percentage breakdown of purchases by account type — GPO, WAC or 340B — for the NDCs included in a group, brought over from the Variance Reports module
- The number of unique NDC numbers in the medication grouping
- The number of NDCs your institution purchased
The new summary is offered as an interactive card view, consistent with the design and functionality of Build and Compare Populations. We have added a search field to allow users to search medication groups by group name (defined by user), drug name, NDC, GPI and GPI description. Users can also create custom date ranges for drug purchases.
Eventually, we’ll also incorporate a view of real-world data into the medication group cards, as seen in the Variance Reports screenshot below, into the card view. Our goals are to add breakdowns comparing your index results to real-world data, plus the encounter types associated with the NDCs to illustrate what conditions the drugs are being used to treat.
Our goal in designing these enhancements is to simplify the user experience by minimizing clicks and the number of places you need to visit to find useful information.
It’s also the first enhancement to CRCA P&T since last summer, when we debuted our Drug Remittance Dashboard, which organizes data from your hospital’s remittance files for a select group of high-cost specialty medications. It shows purchase price and reimbursement amounts by payer, calculating your margins and offering abundant ways to drill down and analyze drug utilization and payer remittance.
Interested in learning more about CRCA P&T? Contact your Sentry account manager.